{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:31:40Z","timestamp":1761611500834,"version":"3.37.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Iran University of Medical Sciences, Tehran, Iran","award":["28765"],"award-info":[{"award-number":["28765"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229275","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:33:16Z","timestamp":1583173996000},"page":"e0229275","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and na\u00efve HIV-infected individuals"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5367-0847","authenticated-orcid":true,"given":"Farah","family":"Bokharaei-Salim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Esghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Khanaliha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atousa","family":"Fakhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"pone.0229275.ref001","unstructured":"sheet GHAsf. Global HIV & AIDS statistics 2018 fact sheet[online] http:\/\/www.unaids.org\/en\/resources\/fact-sheet. 2018."},{"key":"pone.0229275.ref002","unstructured":"National AIDS Committee Secretariat M, Education oHaM. Islamic Republic of Iran AIDS Progress Report. March 2015."},{"key":"pone.0229275.ref003","first-page":"1178633718788870","article-title":"Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy-Naive patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India","volume":"11","author":"S Sinha","year":"2018","journal-title":"Infectious diseases"},{"issue":"7","key":"pone.0229275.ref004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2221-1691(13)60106-9","article-title":"The emergence of drug resistant HIV variants and novel anti-retroviral therapy","volume":"3","author":"K Paydary","year":"2013","journal-title":"Asian Pacific journal of tropical biomedicine"},{"issue":"9","key":"pone.0229275.ref005","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00705-016-2955-z","article-title":"Antiretroviral drug resistance mutations in naive and experienced patients in Shiraz, Iran, 2014","volume":"161","author":"H Naziri","year":"2016","journal-title":"Arch Virol"},{"issue":"2","key":"pone.0229275.ref006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance","volume":"21","author":"RW Shafer","year":"2007","journal-title":"Aids"},{"issue":"5","key":"pone.0229275.ref007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/135965350400900514","article-title":"Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe","volume":"9","author":"D Pillay","year":"2004","journal-title":"Antivir Ther"},{"issue":"6","key":"pone.0229275.ref008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","article-title":"Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness","volume":"134","author":"MC Weinstein","year":"2001","journal-title":"Annals of internal medicine"},{"issue":"9","key":"pone.0229275.ref009","first-page":"1256","article-title":"Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran","volume":"46","author":"M Farrokhi","year":"2017","journal-title":"Iran. Iranian journal of public health"},{"key":"pone.0229275.ref010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12981-015-0053-z","article-title":"Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand","volume":"12","author":"W Manosuthi","year":"2015","journal-title":"AIDS research and therapy"},{"issue":"6","key":"pone.0229275.ref011","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00705-017-3228-1","article-title":"HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals","volume":"162","author":"R Vahabpour","year":"2017","journal-title":"Arch Virol"},{"issue":"1","key":"pone.0229275.ref012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1348-0421.2003.tb02788.x","article-title":"Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy","volume":"47","author":"S Ibe","year":"2003","journal-title":"Microbiol Immunol"},{"issue":"2","key":"pone.0229275.ref013","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/JCM.01708-06","article-title":"Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs","volume":"45","author":"T Chiba-Mizutani","year":"2007","journal-title":"Journal of clinical microbiology"},{"issue":"8","key":"pone.0229275.ref014","doi-asserted-by":"crossref","first-page":"e71972","DOI":"10.1371\/journal.pone.0071972","article-title":"HIV-1 drug-resistance surveillance among treatment-experienced and -naive patients after the implementation of antiretroviral therapy in Ghana","volume":"8","author":"NI Nii-Trebi","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"pone.0229275.ref015","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"pone.0229275.ref016","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/596486","article-title":"Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy","volume":"48","author":"A Coovadia","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"pone.0229275.ref017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1413-8670(12)70325-2","article-title":"Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia","volume":"16","author":"S Mohamad","year":"2012","journal-title":"The Brazilian Journal of Infectious Diseases"},{"key":"pone.0229275.ref018","unstructured":"Los Alamos, HIV database.[online] www.hiv.lanl.gov\/content\/index. January 2019."},{"issue":"5","key":"pone.0229275.ref019","doi-asserted-by":"crossref","first-page":"e0126955","DOI":"10.1371\/journal.pone.0126955","article-title":"Transmitted Drug Resistance Mutations in Antiretroviral-Naive Injection Drug Users with Chronic HIV-1 Infection in Iran","volume":"10","author":"A Memarnejadian","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"pone.0229275.ref020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jmv.23898","article-title":"Antiretroviral drug resistance among antiretroviral-naive and treatment experienced patients infected with HIV in Iran","volume":"86","author":"K Baesi","year":"2014","journal-title":"J Med Virol"},{"issue":"4","key":"pone.0229275.ref021","doi-asserted-by":"crossref","first-page":"e61864","DOI":"10.1371\/journal.pone.0061864","article-title":"Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011","volume":"8","author":"F Jahanbakhsh","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"pone.0229275.ref022","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"RK Gupta","year":"2018","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"pone.0229275.ref023","doi-asserted-by":"crossref","first-page":"253 e1","DOI":"10.1016\/j.cmi.2018.09.025","article-title":"Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany","volume":"25","author":"M Stecher","year":"2019","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"11","key":"pone.0229275.ref024","doi-asserted-by":"crossref","DOI":"10.3390\/genes8110322","article-title":"Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naive Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health","volume":"8","author":"D Paraskevis","year":"2017","journal-title":"Genes"},{"issue":"1","key":"pone.0229275.ref025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12981-019-0219-1","article-title":"Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil","volume":"16","author":"LD Bahls","year":"2019","journal-title":"AIDS research and therapy"},{"key":"pone.0229275.ref026","article-title":"Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015\/2016 in France","author":"L Assoumou","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"pone.0229275.ref027","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/jmv.24474","article-title":"Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection","volume":"88","author":"F Bokharaei-Salim","year":"2016","journal-title":"J Med Virol"},{"issue":"12","key":"pone.0229275.ref028","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/aid.2010.0324","article-title":"Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan","volume":"27","author":"S Shah","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"pone.0229275.ref029","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/597352","article-title":"Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland","volume":"48","author":"V von Wyl","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"6","key":"pone.0229275.ref030","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/jac\/dkx042","article-title":"Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies\/mL: a 2014 French nationwide study","volume":"72","author":"L Assoumou","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0229275.ref031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12981-017-0133-3","article-title":"HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China","volume":"14","author":"X Lu","year":"2017","journal-title":"AIDS research and therapy"},{"issue":"1","key":"pone.0229275.ref032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12985-018-1112-6","article-title":"Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China","volume":"16","author":"J Li","year":"2019","journal-title":"Virology journal"},{"key":"pone.0229275.ref033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/IDR.S146584","article-title":"High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009\u20132014","volume":"10","author":"HC Tsai","year":"2017","journal-title":"Infection and drug resistance"},{"issue":"2","key":"pone.0229275.ref034","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/QAI.0000000000001285","article-title":"HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa","volume":"75","author":"C Kityo","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0229275.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.247.1","article-title":"Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010\u20132016","volume":"247","author":"K Dong","year":"2019","journal-title":"The Tohoku journal of experimental medicine"},{"issue":"1","key":"pone.0229275.ref036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/QAI.0000000000000221","article-title":"Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study","volume":"67","author":"MR O'Donnell","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"pone.0229275.ref037","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00705-017-3661-1","article-title":"Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonates","volume":"163","author":"F Bokharaei-Salim","year":"2018","journal-title":"Arch Virol"},{"issue":"6","key":"pone.0229275.ref038","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000497036","article-title":"Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9\u201315 Months in 14 Triangular Clinics in Iran, 2015\u20132016","volume":"61","author":"M Mohraz","year":"2018","journal-title":"Intervirology"},{"issue":"1","key":"pone.0229275.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qco.0000200293.45532.68","article-title":"HIV-1 subtypes: epidemiology and significance for HIV management","volume":"19","author":"AM Geretti","year":"2006","journal-title":"Current opinion in infectious diseases"},{"issue":"4","key":"pone.0229275.ref040","first-page":"287","article-title":"Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development","volume":"121","author":"RB Lal","year":"2005","journal-title":"The Indian journal of medical research"},{"issue":"8","key":"pone.0229275.ref041","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00002030-200205240-00007","article-title":"Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy","volume":"16","author":"AJ Frater","year":"2002","journal-title":"AIDS"},{"issue":"2","key":"pone.0229275.ref042","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/135965350501000206","article-title":"Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness","volume":"10","author":"L Bocket","year":"2005","journal-title":"Antivir Ther"},{"issue":"6","key":"pone.0229275.ref043","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/499952","article-title":"Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype","volume":"42","author":"A Vasan","year":"2006","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"pone.0229275.ref044","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/527416","article-title":"Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection","volume":"197","author":"N Kiwanuka","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"pone.0229275.ref045","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/512682","article-title":"HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads","volume":"195","author":"JM Baeten","year":"2007","journal-title":"The Journal of infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:01:45Z","timestamp":1665986505000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229275"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229275","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,3,2]]}}}